Effects of (S)-amlodipine and (R)-amlodipine on L-type calcium channel current of rat ventricular myocytes and cytosolic calcium of aortic smooth muscle cells

Pharmazie

Volumn 63, Issue 6, 2008, Pages 470-474

  Wang, Ru Xing ^a   Jiang, Wen Ping ^b   Li, Xiao Rong ^a   Lai, Li Hong ^b  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM; CALCIUM CHANNEL L TYPE; FURA 2 ACETOXYMETHYL ESTER;

ANIMAL CELL; AORTA MEDIA; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; CYTOSOL; DRUG EFFECT; ELECTRIC POTENTIAL; HEART MUSCLE CELL; IC 50; ISOMER; NONHUMAN; PATCH CLAMP; RAT; STEADY STATE;

AMLODIPINE; ANIMALS; AORTA; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CYTOSOL; FEMALE; INDICATORS AND REAGENTS; KINETICS; MALE; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; SOLUTIONS; STEREOISOMERISM;

EID: 46849110170     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.7857     Document Type: Article

References (25)

1. Arrowsmith JE, Camphell F, Cross E et al. (1986) Long-acting dihydropy-ridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents. J Med Chem 29: 1696-1702.
2. Bojarski J (2002) Stereoselective chromatography of cardiovascular drugs: an update, J Biochem Biophys Methods 54: 197-220.
3. Dahlof B, Sever PS, Poulter NR et al. Prevention of cardiovascular events with an anu'hypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 366: 895-906.
4. Duguay D, Deblois D (2007) Differential regulation of Akt, caspases and MAP kinases underlies smooth muscle cell apoptosis during aortic remodelling in SHR treated with amlodipine. Br J Pharmacol 151: 1315-1323.
5. Formica RN, Friedman AL, Lorber MI, Smith JD, Eisen T, Bia MJ (2006) A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period. Nephrol Dial Transplant 21: 1389-1394.
6. Girard T, Treves S, Censier K, Mueller CR, Zorzato F, Urwyler A (2002) Phenotyping malignant hyperthermia susceptibility by measuring halothane-induced changes in myoplasmic calcium concentration in cultured human skeletal muscle cells. Br J Anaesth 89: 571-579.
7. Goldmann S, Stoltefuss J, Born L (1992) Determination of the absolute configuration of the active amlodipine enantiomer as (-)-S: a correction. J Med Chem 35: 3341-3344.
8. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450.
9. Guo CY, Wu JY, Wu YB, Zhong MZ, Lu HM (2004) Effects of endothelin-1 on hepatic stellate cell proliferation, collagen synthesis and secretion, intra-cellular free calcium concentration. World J Gastroenterol 10:2697-2700.
10. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391: 85-100.
11. 2+ transient in rat myocytes during beta-adrenergic stimulation. J Physiol 505: 385-402.
12. Kelly JG, Malley KO (1992) Clinical pharmacokinetics of calcium antagonists. An update. Clin Pharmacokinet 22: 416-433.
13. Meredith PA, Elliott HL (1992) Clinical pharmacokinetics of amlodipine. Clin Pharmacokinet 22: 22-31.
14. Murdoch D, Heel RC (1991) Amlodipine. A review of its pharmacody-namic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs 41: 478-505.
15. Park JY, Kim KA, Park PW, Lee OJ, Ryu JH, Lee GH, Ha MC, Kim JS, Kang SW, Lee KR (2006) Pharmacokinetic and pharmacodynamic characteristics of a new (S)-Amlodipine formulation in healthy Korean male subjects: a randomized, open-label, two-period, comparative, crossover study. Clin Ther 28: 1837-1847.
16. Pathak L, Hiremath, Kerkar PG, Manade VG (2004) Multicentric, clinical trial of (S)-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension-a randomized, double-blind clinical trial. J Assoc Physicians India 52: 197-202.
17. Pathak LA (2004) Chiral molecules in hypertension: focus on (S)-Amlodipine. J Assoc Physicians India 52: 187-188.
18. Paul PA, Kothekar MA (2006) Development of safer molecules through chirality, Indian J Med Sci 60: 427-437.
19. Payeras AC, Sladek K, Lembo G, Alberici M (2007) Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study. Clin Drug Investig 27: 623-632.
20. Sever PS, Poulter NR, Elliott WJ, Jonsson MC, Black HR, Sever PS, Poulter NR, Elliott WJ, Jonsson MC, Black HR (2006) Blood pressure reduction is not the only determinant of outcome. Circulation 113: 2754-2774.
21. Tytgat J (1994) How to isolate cardiac myocytes. Cardiovasc Res 28: 280-283.
22. Umemoto S, Kawahara S, Hashimoto R, Umeji K, Matsuda S, Tanaka M, Kubo M, Matsuzaki M (2006) Different effects of amlodipine and enalapril on the mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-extracellular signal-regulated kinase pathway for induction of vascular smooth muscle cell differentiation in vivo. Hypertens Res 29: 179-186.
23. Yazawa K, Kaibara M, Ohara M, Kameyama M (1990) An improved method for isolating cardiac myocytes useful for patch-clamp studies. Jap J Physiol 40: 157-163.
24. Zanchetti A, Julius S, Kjeldsen S, Zanchetti A, Julius S, Kjeldsen S, Mclnnes GT, Hua T, Weber M, Laragh JH, Plat F, Battegay E, Calvo-Vargas C, Cieśliński A, Degaute JP, Holwerda NJ, Kobalava J, Pedersen OL, Rudyatmoko FP, Siamopoulos KC, Störset O. (2006) Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial. J Hypertens 24: 2163-2168.
25. 2X nucleotide receptor channels in human airway epithelial cells. J Biol Chem 278: 13398-13408.